Finanças

Notícias Discussões Sinais técnicos Sazonais

Lucro líquido diluído disponível para acionistas ordinários de BEIJING HOTGEN BIOTECH CO LTD.

Dados anuais

2017

2018

2019

2020

2021

2022

2023

2024

TTM

‪‪−800,00 M‬‬

‪0,00‬

‪‪800,00 M‬‬

‪‪1,60 B‬‬

‪‪2,40 B‬‬

Período

Valor

Variação

Variação %

TTM

‪‪−179,23 M‬‬

‪0,00‬

‪0,00‬%

2024

‪‪−179,23 M‬‬

‪‪−206,61 M‬‬

‪−754,53‬%

2023

‪‪27,38 M‬‬

‪‪−917,35 M‬‬

‪−97,10‬%

2022

‪‪944,74 M‬‬

‪‪−1,24 B‬‬

‪−56,78‬%

2021

‪‪2,19 B‬‬

+‪‪2,07 B‬‬

+‪‪1,85 K‬‬%

2020

‪‪112,07 M‬‬

+‪‪78,19 M‬‬

+‪230,80‬%

2019

2018

2017

Dados trimestrais

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪‪−180,00 M‬‬

‪‪−120,00 M‬‬

‪‪−60,00 M‬‬

‪0,00‬

‪‪60,00 M‬‬

Período

Valor

Variação

Variação %

Q4 '24

‪‪−138,59 M‬‬

‪‪−141,42 M‬‬

‪‪−5,00 K‬‬%

Q3 '24

‪‪2,83 M‬‬

+‪‪51,35 M‬‬

—

Q2 '24

‪‪−48,52 M‬‬

‪‪−53,58 M‬‬

‪‪−1,06 K‬‬%

Q1 '24

‪‪5,05 M‬‬

+‪‪32,05 M‬‬

—

Q4 '23

‪‪−27,00 M‬‬

+‪‪3,39 M‬‬

+‪11,15‬%

Q3 '23

‪‪−30,39 M‬‬

‪‪−56,27 M‬‬

‪−217,40‬%

Q2 '23

‪‪25,88 M‬‬

‪‪−33,00 M‬‬

‪−56,04‬%

Q1 '23

‪‪58,88 M‬‬

+‪‪215,66 M‬‬

—

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19